Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis

被引:0
作者
Xiao-Na Xiang
Si-Yi Zhu
Hong-Chen He
Xi Yu
Yang Xu
Cheng-Qi He
机构
[1] West China Hospital,Department of Rehabilitation Medicine
[2] Sichuan University,School of Rehabilitation Sciences
[3] West China School of Medicine,Key Laboratory of Rehabilitation Medicine in Sichuan Province
[4] Sichuan University,Rehabilitation Medicine Centre
[5] West China Hospital,undefined
[6] Sichuan University,undefined
[7] West China Hospital,undefined
[8] Sichuan University,undefined
来源
Stem Cell Research & Therapy | / 13卷
关键词
Mesenchymal stromal cell; Osteoarthritis; Exosome; Regeneration; Cartilage;
D O I
暂无
中图分类号
学科分类号
摘要
Osteoarthritis, as a degenerative disease, is a common problem and results in high socioeconomic costs and rates of disability. The most commonly affected joint is the knee and characterized by progressive destruction of articular cartilage, loss of extracellular matrix, and progressive inflammation. Mesenchymal stromal cell (MSC)-based therapy has been explored as a new regenerative treatment for knee osteoarthritis in recent years. However, the detailed functions of MSC-based therapy and related mechanism, especially of cartilage regeneration, have not been explained. Hence, this review summarized how to choose, authenticate, and culture different origins of MSCs and derived exosomes. Moreover, clinical application and the latest mechanistical findings of MSC-based therapy in cartilage regeneration were also demonstrated.
引用
收藏
相关论文
共 1249 条
[1]  
Hunter DJ(2019)Osteoarthritis Lancet 393 1745-1759
[2]  
Bierma-Zeinstra S(2020)Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the global burden of disease study 2017 Ann Rheum Dis 79 819-828
[3]  
Safiri S(2017)Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016 Lancet 390 1211-1259
[4]  
Kolahi AA(2020)2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee Arthritis Care Res (Hoboken) 72 149-162
[5]  
Smith E(2015)Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression Int J Mol Sci 16 6093-6112
[6]  
Hill C(2018)Defining the osteoarthritis patient: back to the future Osteoarthr Cartil 26 1003-1007
[7]  
Bettampadi D(2018)Emerging role of extracellular vesicles in musculoskeletal diseases Mol Aspects Med 60 123-128
[8]  
Mansournia MA(2012)Cell senescence: a challenge in cartilage engineering and regeneration Tissue Eng Part B Rev 18 270-287
[9]  
Hoy D(2018)Osteoarthritis as a disease of the cartilage pericellular matrix Matrix Biol 71–72 40-50
[10]  
Ashrafi-Asgarabad A(2020)TWIST1-MicroRNA-10a-MAP3K7 axis ameliorates synovitis of osteoarthritis in fibroblast-like synoviocytes Mol Ther Nucleic Acids 22 1107-1120